Adicet Bio, Inc. (ACET)
9.59
+0.16
(+1.70%)
USD |
NASDAQ |
Sep 04, 16:00
9.63
+0.04
(+0.42%)
After-Hours: 20:00
Adicet Bio Total Assets (Quarterly) : 148.17M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 148.17M |
| March 31, 2026 | 169.38M |
| December 31, 2025 | 192.36M |
| September 30, 2025 | 140.48M |
| June 30, 2025 | 162.97M |
| March 31, 2025 | 191.27M |
| December 31, 2024 | 220.22M |
| September 30, 2024 | 245.96M |
| June 30, 2024 | 268.84M |
| March 31, 2024 | 293.10M |
| December 31, 2023 | 207.30M |
| September 30, 2023 | 233.26M |
| June 30, 2023 | 277.63M |
| March 31, 2023 | 304.97M |
| December 31, 2022 | 330.69M |
| September 30, 2022 | 354.30M |
| June 30, 2022 | 329.90M |
| March 31, 2022 | 340.45M |
| Date | Value |
|---|---|
| December 31, 2021 | 338.94M |
| September 30, 2021 | 257.20M |
| June 30, 2021 | 268.78M |
| March 31, 2021 | 282.07M |
| December 31, 2020 | 153.84M |
| September 30, 2020 | 150.40M |
| June 30, 2020 | 74.34M |
| March 31, 2020 | 78.21M |
| December 31, 2019 | 81.59M |
| September 30, 2019 | 121.96M |
| June 30, 2019 | 136.66M |
| March 31, 2019 | 145.08M |
| December 31, 2018 | 109.94M |
| September 30, 2018 | 117.43M |
| June 30, 2018 | 128.78M |
| March 31, 2018 | 137.24M |
| December 31, 2017 | 55.19M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.03M |
| Shareholders Equity (Quarterly) | 120.14M |
| Debt to Equity Ratio | 0.107 |
| Current Ratio | 6.709 |
| Net Debt Paydown Yield | 0.84% |